
Belden scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future cash flows and then discounting those back to a present value using a required return.
For Belden, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month Free Cash Flow is about $220 million. Analyst inputs and subsequent extrapolations then project annual Free Cash Flow between 2026 and 2035, with figures such as $250.3 million in 2026 and $322.6 million in 2035, all in $ and expressed before discounting.
After discounting these projected cash flows, the model arrives at an estimated intrinsic value of about $114.24 per share. Compared with the recent share price of $148.00, the DCF output suggests Belden trades at about a 29.5% premium to this estimate. This points to the shares looking overvalued on this specific cash flow based view.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Belden may be overvalued by 29.5%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.
For a profitable company like Belden, the P/E ratio is a useful way to relate what you pay for each share to the earnings the business is currently generating. It gives you a quick sense of how much the market is willing to pay for each dollar of profit.
What counts as a “normal” P/E depends on how quickly investors expect earnings to grow and how risky those earnings appear. Higher growth or lower perceived risk can justify a higher P/E, while lower growth or higher risk typically aligns with a lower multiple.
Belden’s current P/E is 24.14x, which sits below the Electronic industry average of about 28.02x and well below the peer average of 51.23x. Simply Wall St’s Fair Ratio for Belden is 23.88x. This Fair Ratio is a proprietary estimate of what P/E might make sense given factors such as earnings growth, profit margins, industry, market cap and company specific risks.
Because the Fair Ratio is tailored to Belden’s own characteristics, it tends to be more informative than broad peer or industry comparisons. With the Fair Ratio at 23.88x and the current P/E at 24.14x, Belden’s valuation on this measure looks ABOUT RIGHT.
Result: ABOUT RIGHT
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 22 top founder-led companies.
Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. These are simply your story about Belden linked to a set of numbers, where you spell out what you think could happen to its revenue, margins and earnings, connect that to a forecast and fair value, and then compare that fair value with today’s price in an easy to use tool on Simply Wall St’s Community page that updates as fresh news or earnings arrive. For example, one Belden Narrative on the platform currently assigns a fair value of US$169.40 per share based on assumptions like revenue growth of about 4.94%, profit margins around 10.17% and a future P/E of roughly 24.74x. A more cautious investor might plug in lower margins or a different P/E, so you can quickly see how your own view compares with other investors and decide whether the current US$148.00 price looks high, low or roughly in line with what you think the business is worth.
Do you think there's more to the story for Belden? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com